ZNF341 controls STAT3 expression and thereby immunocompetence
- PMID: 29907690
- PMCID: PMC6173313
- DOI: 10.1126/sciimmunol.aat4941
ZNF341 controls STAT3 expression and thereby immunocompetence
Abstract
Signal transducer and activator of transcription 3 (STAT3) is a central regulator of immune homeostasis. STAT3 levels are strictly controlled, and STAT3 impairment contributes to several diseases including the monogenic autosomal-dominant hyper-immunoglobulin E (IgE) syndrome (AD-HIES). We investigated patients of four consanguineous families with an autosomal-recessive disorder resembling the phenotype of AD-HIES, with symptoms of immunodeficiency, recurrent infections, skeletal abnormalities, and elevated IgE. Patients presented with reduced STAT3 expression and diminished T helper 17 cell numbers, in absence of STAT3 mutations. We identified two distinct homozygous nonsense mutations in ZNF341, which encodes a zinc finger transcription factor. Wild-type ZNF341 bound to and activated the STAT3 promoter, whereas the mutant variants showed impaired transcriptional activation, partly due to nuclear translocation failure. In summary, nonsense mutations in ZNF341 account for the STAT3-like phenotype in four autosomal-recessive kindreds. Thus, ZNF341 is a previously unrecognized regulator of immune homeostasis.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Conflict of interest statement
Figures
Similar articles
-
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.Sci Immunol. 2018 Jun 15;3(24):eaat4956. doi: 10.1126/sciimmunol.aat4956. Sci Immunol. 2018. PMID: 29907691 Free PMC article.
-
Inherited human ZNF341 deficiency.Curr Opin Immunol. 2023 Jun;82:102326. doi: 10.1016/j.coi.2023.102326. Epub 2023 Apr 18. Curr Opin Immunol. 2023. PMID: 37080116 Free PMC article. Review.
-
Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.J Allergy Clin Immunol. 2009 Aug;124(2):342-8, 348.e1-5. doi: 10.1016/j.jaci.2009.05.004. Epub 2009 Jul 3. J Allergy Clin Immunol. 2009. PMID: 19577286 Free PMC article.
-
Evaluation of the Role of stat3 in Antibody and TH17-Mediated Responses to Pneumococcal Immunization and Infection by Use of a Mouse Model of Autosomal Dominant Hyper-IgE Syndrome.Infect Immun. 2018 Apr 23;86(5):e00024-18. doi: 10.1128/IAI.00024-18. Print 2018 May. Infect Immun. 2018. PMID: 29463618 Free PMC article.
-
Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.J Clin Immunol. 2017 Feb;37(2):166-179. doi: 10.1007/s10875-017-0369-7. Epub 2017 Feb 14. J Clin Immunol. 2017. PMID: 28197791 Review.
Cited by
-
Inborn errors of immunity with atopic phenotypes: A practical guide for allergists.World Allergy Organ J. 2021 Feb 22;14(2):100513. doi: 10.1016/j.waojou.2021.100513. eCollection 2021 Feb. World Allergy Organ J. 2021. PMID: 33717395 Free PMC article. Review.
-
A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16463-16472. doi: 10.1073/pnas.1901409116. Epub 2019 Jul 25. Proc Natl Acad Sci U S A. 2019. PMID: 31346092 Free PMC article.
-
Prediction of enhancer-promoter interactions using the cross-cell type information and domain adversarial neural network.BMC Bioinformatics. 2020 Nov 7;21(1):507. doi: 10.1186/s12859-020-03844-4. BMC Bioinformatics. 2020. PMID: 33160328 Free PMC article.
-
Recent advances in understanding inherited deficiencies in immunity to infections.F1000Res. 2020 Apr 7;9:F1000 Faculty Rev-243. doi: 10.12688/f1000research.22036.1. eCollection 2020. F1000Res. 2020. PMID: 32308976 Free PMC article. Review.
-
The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.Fam Cancer. 2021 Oct;20(4):363-380. doi: 10.1007/s10689-021-00266-w. Epub 2021 Jun 15. Fam Cancer. 2021. PMID: 34128135
References
-
- Al Khatib S, Keles S, Garcia-Lloret M, Karakoc-Aydiner E, Reisli I, Artac H, Camcioglu Y, Cokugras H, Somer A, Kutukculer N, Yilmaz M, Ikinciogullari A, Yegin O, Yuksek M, Genel F, Kucukosmanoglu E, Baki A, Bahceciler NN, Rambhatla A, Nickerson DW, McGhee S, Barlan IB, Chatila T, Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. The Journal of allergy and clinical immunology 124, 342–348, 348 e341–345 (2009). - PMC - PubMed
-
- de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Janniere L, Fieschi C, Stephan JL, Boileau C, Lyonnet S, Jondeau G, Cormier-Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L, Rodriguez-Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, Chapel H, Reid B, Roifman C, Nadal D, Reichenbach J, Caragol I, Garty BZ, Dogu F, Camcioglu Y, Gulle S, Sanal O, Fischer A, Abel L, Stockinger B, Picard C, Casanova JL, Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. The Journal of experimental medicine 205, 1543–1550 (2008). - PMC - PubMed
-
- Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, Kanno Y, Spalding C, Elloumi HZ, Paulson ML, Davis J, Hsu A, Asher AI, O’Shea J, Holland SM, Paul WE, Douek DC, Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773–776 (2008). - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
